Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas

Journal of Neuro-Oncology

Volumn 44, Issue 1, 1999, Pages 77-83

  Jakacki, Regina I ^a,c   Siffert, Joao ^b   Jamison, Cheryl ^a   Velasquez, Linda ^b   Allen, Jeffrey C ^b  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

CCNU; Chemoradiotherapy; Dose intensity; Gliomas; Peripheral blood stem cells; Procarbazine

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; BLOOD TOXICITY; BRAIN EDEMA; BRAIN STEM; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD STEM CELL; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; GLIOMA; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LOMUSTINE; MALE; PROCARBAZINE; RADIOTHERAPY, ADJUVANT; VINCRISTINE;

EID: 0032743338     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006360222643     Document Type: Article

References (20)

1. Freeman CR, Krischer JP, Sanford A, Cohen ME, Burger PC, Del Carpio R, Halperin EC, Munoz L, Friedman HS, Kun LE: Final results of a study of escalating doses of hyper-fractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 27: 197-206, 1993
2. Finlay JL, Boyett JM, Yates AJ, Wisoff JK, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, Turski PA, Wara WM, Edwards M, Sutton LN, Berger MS, Epstein F, Ayers G, Allen JC. Packer RJ: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine and prednisone with the eight-drugs-in-1-day regimen. J Clin Oncol 13: 112-123, 1995
3. Sposto R, Ertel IJ, Jenkin RDT, Boesel CP, Venes JL, Ortega JA, Evans AE, Wara W, Hammond D: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. J Neuro-Oncol 7: 165-177, 1989
4. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321-324, 1990
5. Hryniuk W: The importance of dose-intensity in the outcome of chemotherapy. In: DeVita VT Jr, Helman S, Rosenberg SA (eds): Important Advances in Oncology. Lippincott, Philadelphia, PA, 1989, pp 121-141
6. Jakacki RI, Jamison C, Mathews VP, Heilman DK, Dropcho E, Cornetta K, Macdonald DR, Williams DA: Dose-intensification of procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. Med Pediatr Oncol 31: 483-490, 1998
7. Siemann DW, Hill SA: Enhanced tumor response through therapies combining CCNU, miso and radiation. Int J Radiat Oncol Biol Phys 10: 1623, 1984
8. Wheeler KT, Deen DF, Wilson CB, Williams ME, Sheppard S: BCNU modification of the in vitro radiation response. Int J Radiat Oncol Biol Phys 2: 79-88 1977
9. Gnekow AK: Recommendations of the Brain Tumor Sub-committee for the reporting of trials. Med Ped Oncol 24: 104-108, 1995
10. Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransohoff J, Wilson CG, Gehan EA, Strike TA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic glioma: a cooperative clinical trial. J Neurosurg 49: 333-343, 1978
11. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CG, Strike TA: Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. NEJM 303: 1323-1329, 1980
12. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A Joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group Study. Cancer 52: 997-1007, 1983
13. Ushio T, Hayakawa T, Hasegawa H, Yamada K, Arita N: Chemotherapy of malignant gliomas. Neurosurg Rev 7: 3-12, 1984
14. Eyre HJ, Quagliana JM, Eltringham JR, Frank J, O'Bryan RM, McDonald B, Rivkin SE: Randomized comparison of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. J Neuro-Oncol 1: 171-177, 1983
15. Comella G, Scoppa G, De Marco M, Ianniello GP, Melillo G, Coucourde F and Zarrilli D: Radiotherapy and combination chemotherapy with carmustine, vincristine and procarbazine in primary brain tumors. J Neuro-Oncol 3: 13-17, 1985
16. Stewart DJ, Leavens M, MaorM, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42: 2474-2479, 1982
17. Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho F, Stewart D, Schold C Jr., Wainman N, Eisenhauser E: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013-2021, 1994
18. Postma TJ, van Groeningen CJ, Witjes RJGM, Weerts JGE, Kralendonk JH, Heimans JJ: Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma. J Neuro-Oncol 38: 69-75, 1998
19. Griffin TW, Rasey JS, Bleyer WA: The effect of photon irradiation on blood-brain barrier permeability to methotrexate in mice. Cancer 40: 1109-1111, 1977
20. Hoagland HC: Hematologic complications of cancer chemotherapy. In: Perry MC (ed) The Chemotherapy Source Book. Williams and Wilkins, Baltimore, MD, 1992, pp 498-502